B2B Pharmaceutical · Digital Advertising & Lead Generation

Building a more efficient B2B lead-generation engine for a pharmaceutical organisation

A joined-up programme combining precision paid media, conversion optimisation, search visibility and measurement to improve how specialist commercial demand was captured.

The organisation had an established digital presence but needed to generate stronger commercial demand from a specialist B2B audience while using media investment more efficiently and improving the quality of performance signals available to the team.

The challenge

A specialist pharmaceutical organisation needed to generate more relevant B2B demand without simply increasing paid media activity. Its audiences were narrow, technically informed and commercially valuable, so broad-reach advertising risked creating visibility without enough meaningful action.

The challenge therefore sat across the full lead-generation journey: targeting the right decision-makers, ensuring paid traffic reached clear and conversion-ready pages, maintaining search visibility, and improving the measurement framework used to judge performance.

The engagement required more than campaign management in isolation. DSC combined media optimisation with funnel review, search and content insight, and performance analysis so that acquisition decisions could be made against a clearer commercial picture.

What we did

Establish the commercial performance baseline
We reviewed performance across lead submissions, audience acquisition, paid media efficiency and search visibility to identify where the existing digital funnel was producing value and where budget or effort could be tightened.
Refine paid media around higher-value demand
We sharpened targeting and campaign focus around relevant B2B audiences, using paid media as a demand-capture mechanism rather than an indiscriminate awareness channel. Optimisation decisions were guided by lead and conversion signals rather than impression volume alone.
Improve the path from click to enquiry
We reviewed the landing-page and conversion journey so that media activity, message relevance and calls to action worked together more effectively. The emphasis was on reducing friction and giving specialist prospects a clearer route to engage.
Connect acquisition activity to better measurement
We strengthened the performance view across advertising, analytics and search data so the team could distinguish reach from commercially useful activity and make more informed optimisation decisions.
Extend the model across search, content and ongoing optimisation
With the core lead-generation model established, we developed the programme into a more joined-up approach spanning paid media, search visibility, content structure, conversion optimisation and data governance, while keeping commercial demand and lead quality at the centre.

What the organisation received

More efficient lead generation

The internal performance review records higher lead submissions while paid media spend was reduced, indicating a more efficient demand-generation model.

Broader qualified reach

New-user acquisition increased, giving the organisation greater exposure to potential commercial audiences without relying on higher paid-media volume.

Stronger search visibility

Organic search visibility increased over the comparative period, adding a second source of discoverability alongside paid acquisition.

A more connected optimisation model

Paid media, landing-page experience, search and measurement were managed as related parts of the same lead-generation system rather than isolated channels.

Evidence

Evidence and scope

The internal performance analysis records higher lead submissions and new-user acquisition alongside lower paid media spend, with organic search visibility also increasing over the comparative period.

Method

Comparative review of first-party lead-form activity, audience acquisition, paid media expenditure and search visibility, combined with ongoing campaign and conversion-funnel optimisation.

Evidence context

The evidence relates to a B2B pharmaceutical digital-growth programme in which DSC managed and optimised acquisition activity across paid media, site conversion, search visibility and measurement. The public case intentionally removes the client, product, market, platform-account and financial details that could identify the organisation.

Limitations

The source pack reports relative performance changes but does not expose every absolute baseline or a controlled causal test. The observed improvements should therefore be treated as programme-level performance evidence rather than proof that any single tactic caused the change. Exact percentage figures are withheld from the public draft until the baseline, comparison period and publication permission are approved in Evidence Records.